356 related articles for article (PubMed ID: 25861727)
1. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
2. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA based theranostics for brain cancer: basic principles.
Petrescu GED; Sabo AA; Torsin LI; Calin GA; Dragomir MP
J Exp Clin Cancer Res; 2019 May; 38(1):231. PubMed ID: 31142339
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.
Shea A; Harish V; Afzal Z; Chijioke J; Kedir H; Dusmatova S; Roy A; Ramalinga M; Harris B; Blancato J; Verma M; Kumar D
Cancer Med; 2016 Aug; 5(8):1917-46. PubMed ID: 27282910
[TBL] [Abstract][Full Text] [Related]
5. Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b.
El Fatimy R; Subramanian S; Uhlmann EJ; Krichevsky AM
Mol Ther; 2017 Feb; 25(2):368-378. PubMed ID: 28153089
[TBL] [Abstract][Full Text] [Related]
6. Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy.
Erel-Akbaba G; Carvalho LA; Tian T; Zinter M; Akbaba H; Obeid PJ; Chiocca EA; Weissleder R; Kantarci AG; Tannous BA
ACS Nano; 2019 Apr; 13(4):4028-4040. PubMed ID: 30916923
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway.
Wu T; Li Y; Liu B; Zhang S; Wu L; Zhu X; Chen Q
PLoS One; 2016; 11(2):e0149361. PubMed ID: 26871431
[TBL] [Abstract][Full Text] [Related]
8. Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model.
Stephen ZR; Chiarelli PA; Revia RA; Wang K; Kievit F; Dayringer C; Jeon M; Ellenbogen R; Zhang M
Cancer Res; 2019 Sep; 79(18):4776-4786. PubMed ID: 31331912
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of sericin-based conjugates by click chemistry: enhancement of sunitinib bioavailability and cell membrane permeation.
Scrivano L; Iacopetta D; Sinicropi MS; Saturnino C; Longo P; Parisi OI; Puoci F
Drug Deliv; 2017 Nov; 24(1):482-490. PubMed ID: 28181828
[TBL] [Abstract][Full Text] [Related]
10. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.
Kouri FM; Hurley LA; Daniel WL; Day ES; Hua Y; Hao L; Peng CY; Merkel TJ; Queisser MA; Ritner C; Zhang H; James CD; Sznajder JI; Chin L; Giljohann DA; Kessler JA; Peter ME; Mirkin CA; Stegh AH
Genes Dev; 2015 Apr; 29(7):732-45. PubMed ID: 25838542
[TBL] [Abstract][Full Text] [Related]
11. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme.
Mekala JR; Adusumilli K; Chamarthy S; Angirekula HSR
Metab Brain Dis; 2023 Aug; 38(6):1801-1829. PubMed ID: 37249862
[TBL] [Abstract][Full Text] [Related]
12. miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks.
Chen L; Kang C
Oncotarget; 2015 Nov; 6(36):38628-42. PubMed ID: 26439688
[TBL] [Abstract][Full Text] [Related]
13. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.
Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE
Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma.
Grafals-Ruiz N; Sánchez-Álvarez AO; Santana-Rivera Y; Lozada-Delgado EL; Rabelo-Fernandez RJ; Rios-Vicil CI; Valiyeva F; Vivas-Mejia PE
Front Oncol; 2023; 13():1249649. PubMed ID: 37752997
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells.
Hayward SL; Wilson CL; Kidambi S
Oncotarget; 2016 Jun; 7(23):34158-71. PubMed ID: 27120809
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan decorated layer-by-layer assembled lipid nanoparticles for miR-181a delivery in glioblastoma treatment.
Passos Gibson V; Tahiri H; Yang C; Phan QT; Banquy X; Hardy P
Biomaterials; 2023 Nov; 302():122341. PubMed ID: 37778056
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment.
Huo M; Zhao Y; Satterlee AB; Wang Y; Xu Y; Huang L
J Control Release; 2017 Jan; 245():81-94. PubMed ID: 27863995
[TBL] [Abstract][Full Text] [Related]
18. Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo.
Sarli SL; Fakih HH; Kelly K; Devi G; Rembetsy-Brown JM; McEachern HR; Ferguson CM; Echeverria D; Lee J; Sousa J; Sleiman HF; Khvorova A; Watts JK
Nucleic Acids Res; 2024 May; 52(9):4799-4817. PubMed ID: 38613388
[TBL] [Abstract][Full Text] [Related]
19. Advances in glioblastoma multiforme: Integrating therapy and pathology perspectives.
Shahcheraghi SH; Alimardani M; Lotfi M; Lotfi M; Uversky VN; Guetchueng ST; Palakurthi SS; Charbe NB; Hromić-Jahjefendić A; Aljabali AAA; Gadewar MM; Malik S; Goyal R; El-Tanani M; Mishra V; Mishra Y; Tambuwala MM
Pathol Res Pract; 2024 May; 257():155285. PubMed ID: 38653089
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.
Henriksen M; Johnsen KB; Andersen HH; Pilgaard L; Duroux M
Mol Neurobiol; 2014 Dec; 50(3):896-913. PubMed ID: 24619503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
